whatsapp-logo
User Image

Femoston 1/10 mg 28 tablets

Available at Pharmaegy Pharmacy. Use as directed by your doctor.

Femoston 1/10 mg 28 tablets Composition: Each calendar pack contains 14 pink tablets Estradiol 1 mg (as hemihydrate) 14 yellow tablets Estradiol 1 mg (as hemihydrate) and Dydrogesterone 10 mg. Description: Femoston 1/10 is a continuous sequential hormone replacement therapy (HRT) for postmenopausal women. It combines estradiol a natural form of estrogen with dydrogesterone a synthetic progestogen to alleviate menopausal symptoms and prevent endometrial hyperplasia caused by estrogen alone. Indications for use: Treatment of estrogen deficiency symptoms in postmenopausal women Prevention of osteoporosis in postmenopausal women at high risk when other options are unsuitable Femoston 1/10 should be used in women with an intact uterus. Dosage and administration: One tablet daily continuously for 28 days 14 pink tablets followed by 14 yellow tablets Tablets should be swallowed whole with water at the same time each day A new pack is started the day after the previous one ends For initiation or continuation of HRT the lowest effective dose should be used for the shortest duration. Contraindications: Known past or suspected breast cancer Known or suspected estrogen-dependent malignant tumors e.g endometrial cancer Undiagnosed vaginal bleeding Untreated endometrial hyperplasia History or presence of venous thromboembolism Active or recent arterial thromboembolic disease e.g angina myocardial infarction Acute liver disease or liver function abnormalities Known hypersensitivity to active substances or excipients Porphyria. Precautions: HRT should only be started for menopausal symptoms that significantly affect quality of life Periodic evaluation of benefits and risks is required Use caution in patients with history of estrogen-sensitive cancers thromboembolism liver disorders or endometriosis Patients should be monitored for signs of cardiovascular disease breast cancer and endometrial pathology HRT does not prevent dementia or cardiovascular disease. Pregnancy and lactation: Femoston is contraindicated during pregnancy and breastfeeding If pregnancy occurs treatment must be discontinued immediately. Side effects: Common side effects may include Headache breast pain tenderness abdominal pain nausea vaginal discharge menstrual-like bleeding Uncommon or rare Migraine mood changes rash weight change edema venous thromboembolism gallstones. Storage conditions: Store below 30°C Keep out of reach of children Store in the original packaging to protect from moisture and light. Packaging: Each carton contains one calendar pack with 28 film-coated tablets (14 pink + 14 yellow) and a package insert.

Femoston 1/10 mg 28 tablets


Description

Femoston 1/10 mg 28 tablets Composition: Each calendar pack contains 14 pink tablets Estradiol 1 mg (as hemihydrate) 14 yellow tablets Estradiol 1 mg (as hemihydrate) and Dydrogesterone 10 mg. Description: Femoston 1/10 is a continuous sequential hormone replacement therapy (HRT) for postmenopausal women. It combines estradiol a natural form of estrogen with dydrogesterone a synthetic progestogen to alleviate menopausal symptoms and prevent endometrial hyperplasia caused by estrogen alone. Indications for use: Treatment of estrogen deficiency symptoms in postmenopausal women Prevention of osteoporosis in postmenopausal women at high risk when other options are unsuitable Femoston 1/10 should be used in women with an intact uterus. Dosage and administration: One tablet daily continuously for 28 days 14 pink tablets followed by 14 yellow tablets Tablets should be swallowed whole with water at the same time each day A new pack is started the day after the previous one ends For initiation or continuation of HRT the lowest effective dose should be used for the shortest duration. Contraindications: Known past or suspected breast cancer Known or suspected estrogen-dependent malignant tumors e.g endometrial cancer Undiagnosed vaginal bleeding Untreated endometrial hyperplasia History or presence of venous thromboembolism Active or recent arterial thromboembolic disease e.g angina myocardial infarction Acute liver disease or liver function abnormalities Known hypersensitivity to active substances or excipients Porphyria. Precautions: HRT should only be started for menopausal symptoms that significantly affect quality of life Periodic evaluation of benefits and risks is required Use caution in patients with history of estrogen-sensitive cancers thromboembolism liver disorders or endometriosis Patients should be monitored for signs of cardiovascular disease breast cancer and endometrial pathology HRT does not prevent dementia or cardiovascular disease. Pregnancy and lactation: Femoston is contraindicated during pregnancy and breastfeeding If pregnancy occurs treatment must be discontinued immediately. Side effects: Common side effects may include Headache breast pain tenderness abdominal pain nausea vaginal discharge menstrual-like bleeding Uncommon or rare Migraine mood changes rash weight change edema venous thromboembolism gallstones. Storage conditions: Store below 30°C Keep out of reach of children Store in the original packaging to protect from moisture and light. Packaging: Each carton contains one calendar pack with 28 film-coated tablets (14 pink + 14 yellow) and a package insert.

Highlights

  • .

  • .

Directions for use

Storage

Administration Instructions

Warning

Precaution

Femoston 1/10 mg 28 tablets

EGP 275.00 EGP 412.5 33% off

In stock
  • SKU
  • Pack Size
  • Unit Count
  • Country
  • Free Shipping
    For orders from $50
  • Support 24/7
    Call us any time
  • 100% Safety
    Only secure payments
  • Hot Offers
    Discounts up to 90%